SCHEMBL22719411

SCHEMBL22719411

N#CC1(Cc2cccc(C(F)(F)F)c2)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 10/20 0.57
▸ CYP3A4 P08684 5/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ CYP2C8 P10632 1/20 0.57
▸ PKLR P30613 1/20 0.44
▸ GAA P10253 1/20 0.41
▸ USP2 O75604 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ SLC6A7 Q99884 1/20 0.39
▸ GPR142 Q7Z601 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ BCR P11274 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GPR52 Q9Y2T5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453812 1.00 CYP46A1 (0.57) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL22719206 0.91 CYP46A1 (0.60) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL29453726 0.91 CYP46A1 (0.60) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL22728370 0.90 CYP46A1 (0.44) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL29453798 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL22719439 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL22719409 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL29453744 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL22719457 0.87 CYP3A4 (0.53) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8
SCHEMBL29453789 0.87 CYP3A4 (0.53) CYP46A1CYP3A4CYP2C19CYP2C9CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261510-A1 NEUROACTIVE STEROID FOR THE TREATMENT OF ALZHEIMER'S DISEASE SAGE THERAPEUTICS, INC. (US) 2022-12-15 — — WO disclosed
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback